<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Control of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> is the main objective of treatment for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, as these patients have a reduced sensitivity to <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e>, disappearance of symptoms may not correlate with efficient control of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to determine in a group of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> whether treatment with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> suppressed pathological <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> once the symptoms of reflux had been controlled and the associated inflammatory lesions cured </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Eighteen consecutive patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were studied, <z:hpo ids='HP_0000001'>all</z:hpo> of whom presented with heartburn </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-four-hour oesophageal pH monitoring before treatment showed pathological <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> cases: median percentage of total time with pH less than 4, 22 (range 8-52) per cent </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (dose 20-60 mg/day) until symptoms were controlled </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: While on therapy, pH was reduced (median percentage of total time with pH less than 4, 3 versus 22 per cent; P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>However, three patients had persistent pathological rates of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Disappearance of symptoms is not a good indicator of control of pathological <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> in patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty-four-hour pH monitoring should be performed for proper adjustment of the dose of medication </plain></SENT>
</text></document>